Pharma Focus Europe

Selvita Introduces Biologic Drug Discovery and Development Services

Monday, March 18, 2024

Selvita S.A. has announced a strategic initiative to expand its service portfolio significantly, marking its entry into the field of biologic drug discovery and development. This expansion includes the addition of comprehensive capabilities in therapeutic antibody discovery and development.

To facilitate this venture, Selvita plans to assemble a team of experts specializing in therapeutic antibody discovery and development and will lease fully equipped laboratories for their work.

The company's new research facility will be located in Wroclaw, Poland, with over 400 sq m of laboratory space and necessary infrastructure. Equipment for antibody discovery-related research studies has already been acquired. Initially, Selvita intends to hire 16 highly experienced scientists, previously associated with Pure Biologics, who specialize in antibody engineering, with plans to double this number within three years.

Milosz Gruca, PhD, Chief Commercial Officer and Executive VP at Selvita, expressed excitement about the expansion, stating, "We are thrilled to announce the enhancement of our service portfolio with a comprehensive suite of capabilities dedicated to antibody-based drug discovery and development. Leveraging the advanced research infrastructure and exceptional team of scientists at our Wroclaw site, we are well-positioned to deliver highly sought-after services to our clients."

Acknowledging the growth potential in the biologics sector, Selvita aims to capitalize on emerging opportunities. This strategic move not only broadens Selvita's portfolio but also opens doors to new markets and growth opportunities. By venturing into biologics, Selvita aims to complement its existing services in small molecule discovery and development.

Furthermore, this expansion aligns with Selvita's commitment to offering comprehensive solutions, positioning itself as a preferred partner for companies seeking high-quality services in both small molecules and biologics discovery and development.

 

Source: prnewswire.com

magazine-slider-img
Thermo Fisher Scientific - mRNA ServicesWorld Orphan Drug Congress 2024World Vaccine Congress Europe 2024Advanced Therapies USA 2024
cytiva